Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Kyle Grose, PharmD, Karen K. Ballen, MD, Tamila L Kindwall-Keller, DO, Kathlene DeGregory, PharmD, BCOP, Gina Petroni, PhD, Gerald R. Donowitz, MD, Brian Wispelwey, MD, Costi Sifri, MD, Leonid Volodin, MD

Blood (2018) 132 (Supplement 1): 3435.

https://doi.org/10.1182/blood-2018-99-111990

Published: 2018

Journal Articles

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Alfaraj Abeer, MBBS, Daniel R Reed, MD, Gina Petroni, PhD, Sandra Monson, PhD, Paige Williams, Kathlene DeGregory, PharmD, BCOP, Leonid Volodin, MD, Tamila L Kindwall-Keller, DO, Karen K. Ballen, MD

Blood (2018) 132 (Supplement 1): 5708.

https://doi.org/10.1182/blood-2018-99-117068

Published: 2018

Journal Articles

Impact of Active Maintenance Treatment (MT) Compared to No MT on the Quality of Life (QoL) of Patients with Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT)

Jason Tay, MD FRCPC, Ravi Vij, MDMBA, Maxim Norkin, MD, Shaji K Kumar, MD, Tamila L Kindwall-Keller, DO, Jenna S Roberts, PhD, Darrell J White, MD, Robert P Wood, BSc, Sophee E Blanthorn-Hazell, MSc, BSc, Adriana C. Rossi, MDMSc, Sujith Dhanasiri, MSc, Faiza Zafar, MPAS, Kim Newhouse, BSc. , BScN, McCurdy R Arleigh, MD MHA, FRCPC

Blood (2017) 130 (Supplement 1): 2150.

https://doi.org/10.1182/blood.V130.Suppl_1.2150.2150

Published: 2017

Journal Articles

The Impact of Maintenance Therapy in the Treatment of Multiple Myeloma with a Subset Analysis on Patients Who Achieve a Complete Response (CR) or Better: A Retrospective Analysis

Louise Man, MD, Bethany Horton, PhD, Anjali Bal, MD, Tamila L Kindwall-Keller, DO, Laahn H. Foster, MD

Blood (2017) 130 (Supplement 1): 4548.

https://doi.org/10.1182/blood.V130.Suppl_1.4548.4548

Published: 2017

Journal Articles

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Johan Thörlén, MD, Olle Ringdén, MD, PhD, Jennifer Le Rademacher, PhD, Minoo Battiwalla, MD, MS, Junfang Chen, MS, Vincent T. Ho, MD, Partow Kebriaei, MD, Carolyn A. Keever-Taylor, PhD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Michael Lill, MD, BS, Tracey A. O’Brien, FRACP, MBChB, MHL, BSc, Miguel Angel Perales, MD, Vanderson Rocha, MD, PhD, Bipin N. Savani, MD, David Szwajcer, MD, FRCPC, David Valcarcel, MD, Mary Eapen, MBBS, MS

Blood (2013) 122 (21): 3342.

https://doi.org/10.1182/blood.V122.21.3342.3342

Published: 2013

Journal Articles

Charlson Comorbidity Index (CCI) and Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Do Not Predict Transplant Related Mortality (TRM) and Post-Transplant Outcomes In Young Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation

Oana V. Paun, MD, Tamila L. Kindwall-Keller, DO, Hillard M. Lazarus, MD, Mary J. Laughlin, MD, Paolo F. Caimi, MD, Merle J. Kolk, Richard J. Creger, Pharm D, Huda Salman, MD, Stanton L. Gerson, MD, Brenda W Cooper, MD

Blood (2013) 122 (21): 4582.

https://doi.org/10.1182/blood.V122.21.4582.4582

Published: 2013

Journal Articles

Very Low to Low Doses of Continuous Azacitidine in Combination with Standard Doses of Lenalidomide and Low-Dose Dexamethasone (Rd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Interim Results of a Phase I/II Study

Frederic J. Reu, MD, Shahper N Khan, PhD, Reda Z Mahfouz, MD/PhD, Robert M Dean, MD, Beth Faiman, CNP, Janice Reed, RN, Mary Ann Karam, RN, Kimberly Hamilton, RN, Sherry Fada, Matt Kalaycio, MD, Erica L. Campagnaro, MD, Tamila L. Kindwall-Keller, DO, Jason Valent, M.D., Christy Samaras, DO, Ronald Sobecks, MD, Carolyn Jirousek, R. N., Hien K. Duong, MD, Mohammed Orloff, Ph.D., Yogen Saunthararajah, MD

Blood (2012) 120 (21): 5031.

https://doi.org/10.1182/blood.V120.21.5031.5031

Published: 2012

Journal Articles

BEP Versus BEAM Conditioning for Autologous Hematopoietic Cell Transplantation in Relapsed Lymphoma. A Single Center Retrospective Review of Two Contemporaneous Cohorts

Paolo F. Caimi, MD, Ashley Rosko, MD, Pingfu Fu, Ph., D., Huda S. Salman, MD, Tamila L. Kindwall-Keller, DO, Brenda W. Cooper, MD, Hillard M. Lazarus, MD FACP

Blood (2011) 118 (21): 2019.

https://doi.org/10.1182/blood.V118.21.2019.2019

Published: 2011

Journal Articles

Charlson Comorbidity Index (CCI) Not Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Successfully Predicts Transplant Related Mortality and Post-Transplant Outcomes in Elderly Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation

Tamila L. Kindwall-Keller, DO, Mary J. Laughlin, MD, Pingfu Fu, Ph., D., Hillard M. Lazarus, MD FACP, Paolo F. Caimi, MD, Cynthia Owusu, MD, Merle J. Kolk, Richard J. Creger, Pharm D, Huda S. Salman, MD, Stanton L. Gerson, MD, Kenneth R. Cooke, MD, Brenda W. Cooper, MD

Blood (2011) 118 (21): 3006.

https://doi.org/10.1182/blood.V118.21.3006.3006

Published: 2011

Journal Articles

A Phase I Study of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Relapsed/Refractory Acute Leukemia

Lisa M. Arfons, MD, Mark H. Kirschbaum, MD, Timothy W. Synold, PharmD, Hillard M. Lazarus, MD, Tamila L. Kindwall-Keller, DO, Mary J. Laughlin, MD, Maureen G. Conlan, MD, Joe Seroogy, Larry Doyle, Brenda W. Cooper, MD

Blood (2008) 112 (11): 4038.

https://doi.org/10.1182/blood.V112.11.4038.4038

Published: 2008

Journal Articles

Prospective Phase II Study of Biologic Assignment One Vs Two Unit Umbilical Cord Blood Transplant (UCBT) in the Reduced-Intensity Conditioning Setting.

Tamila L. Kindwall-Keller, DO, Yael Hegerfeldt, MD, Pingfu Fu, PhD, Hillard M. Lazarus, MD, Brenda W. Cooper, MD, Paul Barr, MD, Stanton L. Gerson, MD, Howard Meyerson, MD, Sally Erinc, RN, Richard J. Creger, PharmD, Laura Fanning, PhD, Nicholas Greco, PhD, Peter Haviernik, PhD, Mathew Lesniewski, PhD, Mary J. Laughlin, MD

Blood (2008) 112 (11): 1960.

https://doi.org/10.1182/blood.V112.11.1960.1960

Published: 2008

NARROW

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Impact of Active Maintenance Treatment (MT) Compared to No MT on the Quality of Life (QoL) of Patients with Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT)

The Impact of Maintenance Therapy in the Treatment of Multiple Myeloma with a Subset Analysis on Patients Who Achieve a Complete Response (CR) or Better: A Retrospective Analysis

Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome

Charlson Comorbidity Index (CCI) and Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Do Not Predict Transplant Related Mortality (TRM) and Post-Transplant Outcomes In Young Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation

Very Low to Low Doses of Continuous Azacitidine in Combination with Standard Doses of Lenalidomide and Low-Dose Dexamethasone (Rd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Interim Results of a Phase I/II Study

BEP Versus BEAM Conditioning for Autologous Hematopoietic Cell Transplantation in Relapsed Lymphoma. A Single Center Retrospective Review of Two Contemporaneous Cohorts

Charlson Comorbidity Index (CCI) Not Hematopoietic Cell Transplantation Specific-Comorbidity Index (HCT-CI) Successfully Predicts Transplant Related Mortality and Post-Transplant Outcomes in Elderly Patients Undergoing Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation

A Phase I Study of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Relapsed/Refractory Acute Leukemia

Prospective Phase II Study of Biologic Assignment One Vs Two Unit Umbilical Cord Blood Transplant (UCBT) in the Reduced-Intensity Conditioning Setting.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only